CME/CE Test

Which of the following risk factors should prompt clinicians to recommend a pneumococcal vaccine for a 35-year-old male patient?

Cigarette smoking

Diabetes mellitus

Heart, lung, or liver disease

All of the above

Daniel, age 4, has a cochlear implant. He received a 4-dose series of pneumococcal conjugate vaccine (PCV).

What additional vaccinations, if any, are recommended for Daniel?

No additional vaccinations are recommended for Daniel

A dose of pneumococcal polysaccharide vaccine (PPSV23) at least 8 weeks after completion of the PCV series

An additional dose of PCV15 at least 8 weeks after completion of the series

Two additional doses of PCV15, 1 at least 8 weeks and 1 at least 5 years after completion of the series

Which of the following is the recommended PCV schedule for children ≤ 2 years?

PPSV23 at 6 months, 9 months, 12 months, and 24 months

PCV15 at 3 months, 6 months, 9 months, and 12 to 15 months

PCV13 or PCV15 at 2 months, 4 months, 6 months, and 12 through 15 months

PCV13 at birth, 3 months, and 1 year

Mary, age 66, received a dose of PCV20 at her annual check-up. She had never received a pneumococcal vaccine before.

What additional doses, if any, are recommended for Mary?

No additional dose is required

A dose of PPSV23 at least 1 year later

An additional dose of PCV20 at least 1 year later

What additional doses, if any, are recommended for at-risk adults who have received a single dose of the PPSV23 vaccine?

No additional dose is required

An additional dose of PCV13 or PCV15 at least 1 year after the initial dose

An additional dose of PCV13 at least 8 weeks after the initial dose

An additional dose of PCV15 at least 8 weeks after the initial dose

Since the introduction of a conjugate vaccine for pneumococcus in 2000, rates of invasive pneumococcal disease have declined by:

55% in children and 42% in adults ≥ 65 years

75% in children and 56% in adults ≥ 65 years

38% in children and 52% in adults ≥ 65 years

93% in children and 60% in adults ≥ 65 years

Pneumococcal Disease Prevention: A Virtual Simulation on Best Practices and Overcoming Challenges